Clinical Efficacy of Transurethral Resection of the Prostate Combined with Oral Anticholinergics or Botulinum Toxin–A Injection to Treat Benign Prostatic Hyperplasia with Overactive Bladder, Randomized Clinical Trial Study

Phase 3

Recruiting

• Conditions: TS In patients with benign prostatic hyperplasia.; Personal history of diseases of genitourinary system; Z87.4

• Registration Number: IRCT20201225049827N1
• Lead Sponsor: Shahid Beheshti University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2021

Recruitment & Eligibility

• Status: Recruiting
• Sex: Male
• Target Recruitment: 42

Inclusion Criteria

Obstructive symptoms of urinary obstruction defined by IPSS and enlarged prostate on DRE examination
Consent to enter the study
Existence of LUTS symptoms
OAB and DO approval with biodynamics and Eurodynamics study

Exclusion Criteria

Patients with neurological diseases such as Parkinson's or stroke
Prostate or bladder cancer
People who have had bladder or prostate surgery in the past
Dissatisfaction with enrollment
Allergy to sulifenacin or Botox

Study & Design

• Study Type: interventional
• Study Design: Not specified